RCE
Click for more information
0.00% 53.0¢ recce pharmaceuticals ltd

Recce Pharmaceuticals (ASX:RCE) granted US patent

  1. TheMarketOnline
    7,567 Posts.
    lightbulb Created with Sketch. 1047
    clock Created with Sketch.
    22/07/21
    13:57
    Post #: 54692742
    • Recce Pharmaceuticals (RCE) secures a US patent for its antibiotic product RECCE 327 and antiviral formulation RECCE 529
    • This is the company's fourth of five patents to be granted, following China, Japan and Europe, with only Australia remaining
    • The US is considered the largest and most influential pharmaceutical market in the world, valued at US$339 billion (around A$461 billion)

    Read the Full Article on The Market Herald here
    RCE Price at posting: $1.13 Sentiment: None Disclosure: Not Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply
 

Featured News

BGD Barton share purchase plan strikes a chord for SA gold projects
right-arrow Created with Sketch.
LU7 Lithium Universe shares jump on below-expected SPP result
right-arrow Created with Sketch.
FHE Frontier Energy closes in on $225m debt financing for Waroona Renewable Energy Project
right-arrow Created with Sketch.
ATC Altech targets $5M to charge up CERENERGY battery project
right-arrow Created with Sketch.
RCE Recce Pharmaceuticals up on new antibiotic production milestone
right-arrow Created with Sketch.
TLX Telix Pharmaceuticals granted US-FDA fast track designation for brain cancer detection
right-arrow Created with Sketch.

Top Stories

watchlist Created with Sketch. Add RCE (ASX) to my watchlist
(20min delay)
Last
53.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $108.0M
Open High Low Value Volume
55.0¢ 55.0¢ 53.0¢ $1.769K 3.3K

Buyers (Bids)

No. Vol. Price($)
1 708 53.5¢
 

Sellers (Offers)

Price($) Vol. No.
54.5¢ 14744 1
View Market Depth
Last trade - 10.18am 18/04/2024 (20 minute delay) ?
RCE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.